Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Diffuse Intrinsic Pontine Glioma
Diffuse Intrinsic Pontine Glioma
AbbVie Receives U.S. FDA Rare Pediatric Disease Designation for Investigational ABT-414 for the Treatment of a Type of Pediatric Brain Tumor known as Diffuse Intrinsic Pontine Glioma (DIPG)
Yahoo
Mon, 07/11/16 - 09:17 am
AbbVie
pediatric
brain tumors
Diffuse Intrinsic Pontine Glioma
ABT-414